Canine Atopic Dermatitis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063921
  • May 2021
  • Pharmaceuticals
  • 116 Pages
The Canine Atopic Dermatitis Treatment market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Canine Atopic Dermatitis Treatment market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Zoetis, Virbac, Novartis AG, Boehringer Ingelheim International GmbH, AB Science, TORAY INDUSTRIES, INC., Elanco, Bimeda, Inc., Vetoquinol S.A., Ceva, Boragen Inc.,, Immunomic Therapeutics Inc., Nexvet Biopharma
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Canine Atopic Dermatitis Treatment market along with their effects over the forecast period. Similarly, according to the region Canine Atopic Dermatitis Treatment market research report includes the study of opportunities available in the market situation.

The Canine Atopic Dermatitis Treatment market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Canine Atopic Dermatitis Treatment Market:
The Canine Atopic Dermatitis Treatment market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Zoetis, Virbac, Novartis AG, Boehringer Ingelheim International GmbH, AB Science, TORAY INDUSTRIES, INC., Elanco, Bimeda, Inc., Vetoquinol S.A., Ceva, Boragen Inc.,, Immunomic Therapeutics Inc., Nexvet Biopharma

Canine Atopic Dermatitis Treatment Market Segmentation Analysis:
By Product
Glucocorticoids
Antihistamines
Immunosuppressants
MAbs
Others
Administration
Topical
Oral
Parenteral
Distribution Channel
Retail
E-commerce
Vet Pharmacies

Global Canine Atopic Dermatitis Treatment Market Segmentation by Regions:
In regional analysis, Canine Atopic Dermatitis Treatment market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Canine Atopic Dermatitis Treatment market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Canine Atopic Dermatitis Treatment Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Canine Atopic Dermatitis Treatment Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Canine Atopic Dermatitis Treatment Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Canine Atopic Dermatitis Treatment Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Canine Atopic Dermatitis Treatment Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Canine Atopic Dermatitis Treatment market, according to the key region.
  • To study the Canine Atopic Dermatitis Treatment market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Canine Atopic Dermatitis Treatment market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Canine Atopic Dermatitis Treatment research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Canine Atopic Dermatitis Treatment market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Canine Atopic Dermatitis Treatment market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Canine Atopic Dermatitis Treatment market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Canine Atopic Dermatitis Treatment market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Canine Atopic Dermatitis Treatment market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Zoetis
  • Virbac
  • Novartis AG
  • Boehringer Ingelheim International GmbH
  • AB Science
  • TORAY INDUSTRIES, INC.
  • Elanco
  • Bimeda, Inc.
  • Vetoquinol S.A.
  • Ceva
  • Boragen Inc.,
  • Immunomic Therapeutics Inc.
  • Nexvet Biopharma
  • Glucocorticoids
  • Antihistamines
  • Immunosuppressants
  • MAbs
  • Others
  • Retail
  • E-commerce
  • Vet Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Canine Atopic Dermatitis Treatment Market Snapshot
          2.1.1. Global Canine Atopic Dermatitis Treatment Market By Product,2019
               2.1.1.1.Glucocorticoids
               2.1.1.2.Antihistamines
               2.1.1.3.Immunosuppressants
               2.1.1.4.MAbs
               2.1.1.5.Others
          2.1.2. Global Canine Atopic Dermatitis Treatment Market By Distribution Channel,2019
               2.1.2.1.Retail
               2.1.2.2.E-commerce
               2.1.2.3.Vet Pharmacies
          2.1.3. Global Canine Atopic Dermatitis Treatment Market By End-use,2019
          2.1.4. Global Canine Atopic Dermatitis Treatment Market By Geography,2019

3. Global Canine Atopic Dermatitis Treatment Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Canine Atopic Dermatitis Treatment Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Canine Atopic Dermatitis Treatment Market Size (US$), By Product, 2018 – 2028

5. Global Canine Atopic Dermatitis Treatment Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Canine Atopic Dermatitis Treatment Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Canine Atopic Dermatitis Treatment Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Canine Atopic Dermatitis Treatment Market Size (US$), By End-use, 2018 – 2028

7. Global Canine Atopic Dermatitis Treatment Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Canine Atopic Dermatitis Treatment Market Analysis, 2018 – 2028 
          7.2.1. North America Canine Atopic Dermatitis Treatment Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Canine Atopic Dermatitis Treatment Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Canine Atopic Dermatitis Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Canine Atopic Dermatitis Treatment Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Canine Atopic Dermatitis Treatment Market Analysis, 2018 – 2028 
          7.3.1.  Europe Canine Atopic Dermatitis Treatment Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Canine Atopic Dermatitis Treatment Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Canine Atopic Dermatitis Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Canine Atopic Dermatitis Treatment Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Canine Atopic Dermatitis Treatment Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Canine Atopic Dermatitis Treatment Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Canine Atopic Dermatitis Treatment Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Canine Atopic Dermatitis Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Canine Atopic Dermatitis Treatment Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Canine Atopic Dermatitis Treatment Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Canine Atopic Dermatitis Treatment Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Canine Atopic Dermatitis Treatment Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Canine Atopic Dermatitis Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Canine Atopic Dermatitis Treatment Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Canine Atopic Dermatitis Treatment Market Analysis, 2018 – 2028 
          7.6.1.  MEA Canine Atopic Dermatitis Treatment Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Canine Atopic Dermatitis Treatment Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Canine Atopic Dermatitis Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Canine Atopic Dermatitis Treatment Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Canine Atopic Dermatitis Treatment Providers
        8.4.1 Zoetis
                8.4.1.1 Business Description
                8.4.1.2 Zoetis Geographic Operations
                8.4.1.3 Zoetis Financial Information
                8.4.1.4 Zoetis Product Positions/Portfolio
                8.4.1.5 Zoetis Key Developments
        8.4.2 Virbac
                8.4.2.1 Business Description
                8.4.2.2 Virbac Geographic Operations
                8.4.2.3 Virbac Financial Information
                8.4.2.4 Virbac Product Positions/Portfolio
                8.4.2.5 Virbac Key Developments
        8.4.3 Novartis AG
                8.4.3.1 Business Description
                8.4.3.2 Novartis AG Geographic Operations
                8.4.3.3 Novartis AG Financial Information
                8.4.3.4 Novartis AG Product Positions/Portfolio
                8.4.3.5 Novartis AG Key Developments
        8.4.4 Boehringer Ingelheim International GmbH
                8.4.4.1 Business Description
                8.4.4.2 Boehringer Ingelheim International GmbH Geographic Operations
                8.4.4.3 Boehringer Ingelheim International GmbH Financial Information
                8.4.4.4 Boehringer Ingelheim International GmbH Product Positions/Portfolio
                8.4.4.5 Boehringer Ingelheim International GmbH Key Developments
        8.4.5 AB Science
                8.4.5.1 Business Description
                8.4.5.2 AB Science Geographic Operations
                8.4.5.3 AB Science Financial Information
                8.4.5.4 AB Science Product Positions/Portfolio
                8.4.5.5 AB Science Key Developments
        8.4.6 TORAY INDUSTRIES, INC.
                8.4.6.1 Business Description
                8.4.6.2 TORAY INDUSTRIES, INC. Geographic Operations
                8.4.6.3 TORAY INDUSTRIES, INC. Financial Information
                8.4.6.4 TORAY INDUSTRIES, INC. Product Positions/Portfolio
                8.4.6.5 TORAY INDUSTRIES, INC. Key Developments
        8.4.7 Elanco
                8.4.7.1 Business Description
                8.4.7.2 Elanco Geographic Operations
                8.4.7.3 Elanco Financial Information
                8.4.7.4 Elanco Product Positions/Portfolio
                8.4.7.5 Elanco Key Developments
        8.4.8 Bimeda, Inc.
                8.4.8.1 Business Description
                8.4.8.2 Bimeda, Inc. Geographic Operations
                8.4.8.3 Bimeda, Inc. Financial Information
                8.4.8.4 Bimeda, Inc. Product Positions/Portfolio
                8.4.8.5 Bimeda, Inc. Key Developments
        8.4.9 Vetoquinol S.A.
                8.4.9.1 Business Description
                8.4.9.2 Vetoquinol S.A. Geographic Operations
                8.4.9.3 Vetoquinol S.A. Financial Information
                8.4.9.4 Vetoquinol S.A. Product Positions/Portfolio
                8.4.9.5 Vetoquinol S.A. Key Developments
        8.4.10 Ceva
                8.4.10.1 Business Description
                8.4.10.2 Ceva Geographic Operations
                8.4.10.3 Ceva Financial Information
                8.4.10.4 Ceva Product Positions/Portfolio
                8.4.10.5 Ceva Key Developments
        8.4.11 Boragen Inc.,
                8.4.11.1 Business Description
                8.4.11.2 Boragen Inc., Geographic Operations
                8.4.11.3 Boragen Inc., Financial Information
                8.4.11.4 Boragen Inc., Product Positions/Portfolio
                8.4.11.5 Boragen Inc., Key Developments
        8.4.12 Immunomic Therapeutics Inc.
                8.4.12.1 Business Description
                8.4.12.2 Immunomic Therapeutics Inc. Geographic Operations
                8.4.12.3 Immunomic Therapeutics Inc. Financial Information
                8.4.12.4 Immunomic Therapeutics Inc. Product Positions/Portfolio
                8.4.12.5 Immunomic Therapeutics Inc. Key Developments
        8.4.13 Nexvet Biopharma
                8.4.13.1 Business Description
                8.4.13.2 Nexvet Biopharma Geographic Operations
                8.4.13.3 Nexvet Biopharma Financial Information
                8.4.13.4 Nexvet Biopharma Product Positions/Portfolio
                8.4.13.5 Nexvet Biopharma Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Canine Atopic Dermatitis Treatment Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Canine Atopic Dermatitis Treatment Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Canine Atopic Dermatitis Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Canine Atopic Dermatitis Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Canine Atopic Dermatitis Treatment Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Canine Atopic Dermatitis Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Canine Atopic Dermatitis Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Canine Atopic Dermatitis Treatment Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Canine Atopic Dermatitis Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Canine Atopic Dermatitis Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Canine Atopic Dermatitis Treatment Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Canine Atopic Dermatitis Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Canine Atopic Dermatitis Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Canine Atopic Dermatitis Treatment Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Canine Atopic Dermatitis Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Canine Atopic Dermatitis Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Canine Atopic Dermatitis Treatment: Market Segmentation 
FIG. 2 Global Canine Atopic Dermatitis Treatment Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Canine Atopic Dermatitis Treatment Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Canine Atopic Dermatitis Treatment Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Canine Atopic Dermatitis Treatment Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Canine Atopic Dermatitis Treatment Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Canine Atopic Dermatitis Treatment Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Canine Atopic Dermatitis Treatment Providers, 2019
FIG. 11 Global Canine Atopic Dermatitis Treatment Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Canine Atopic Dermatitis Treatment Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Canine Atopic Dermatitis Treatment Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Canine Atopic Dermatitis Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Canine Atopic Dermatitis Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Canine Atopic Dermatitis Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Canine Atopic Dermatitis Treatment Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Canine Atopic Dermatitis Treatment Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Canine Atopic Dermatitis Treatment market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Canine Atopic Dermatitis Treatment Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Canine Atopic Dermatitis Treatment Market Value, By Segment1, 2018 – 2028
TABLE  North America Canine Atopic Dermatitis Treatment Market Value, By Segment2, 2018 – 2028
TABLE  North America Canine Atopic Dermatitis Treatment Market Value, By Country, 2018 – 2028
TABLE  Europe Canine Atopic Dermatitis Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Europe Canine Atopic Dermatitis Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Europe Canine Atopic Dermatitis Treatment Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Canine Atopic Dermatitis Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Canine Atopic Dermatitis Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Canine Atopic Dermatitis Treatment Market Value, By Country, 2018 – 2028
TABLE  Latin America Canine Atopic Dermatitis Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Canine Atopic Dermatitis Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Canine Atopic Dermatitis Treatment Market Value, By Country, 2018 – 2028
TABLE  MEA Canine Atopic Dermatitis Treatment Market Value, By Segment1, 2018 – 2028
TABLE  MEA Canine Atopic Dermatitis Treatment Market Value, By Segment2, 2018 – 2028
TABLE  MEA Canine Atopic Dermatitis Treatment Market Value, By Country, 2018 – 2028
TABLE  Zoetis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Virbac: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AB Science: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  TORAY INDUSTRIES, INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Elanco: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bimeda, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Vetoquinol S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ceva: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boragen Inc.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Immunomic Therapeutics Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Nexvet Biopharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Canine Atopic Dermatitis Treatment Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Canine Atopic Dermatitis Treatment Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Canine Atopic Dermatitis Treatment Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Canine Atopic Dermatitis Treatment Market, By Geography, 2019 (US$ Mn)
FIG.  Global Canine Atopic Dermatitis Treatment Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Canine Atopic Dermatitis Treatment Providers, 2016
FIG.  Global Canine Atopic Dermatitis Treatment Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Antihistamines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Immunosuppressants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global MAbs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Canine Atopic Dermatitis Treatment Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global E-commerce Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Vet Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Canine Atopic Dermatitis Treatment Market Value, 2018 – 2028, (US$ Mn)